Taiwan · Series A startup

Who invested in ACT Genomics

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 31 Oct 2026

$8.0Mraised across 1 round since 2015, from 1 source

Latest round
Series A, $8.0MFeb 2015
Investors
0
See who backed them

The rounds

  1. Feb 2015
    Series A$8.0M

    No investor was named in the report.

    From a historical funding record

Founders and team

From ACT Genomics's own website: 1 founder.

Hua Chien ChenChief Executive Officer & Co-Founder

AdvisersShu Jen Chen

Also claim to have backed them

These 2 firms list ACT Genomics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

UMC CapitalVC firmPer its own site
DRIVE CatalystCorporate VCPer its own site

Quick answers about ACT Genomics

How much has ACT Genomics raised?

ACT Genomics has raised $8.0M across 1 round since 2015.

When did ACT Genomics last raise?

ACT Genomics's most recent round was a Series A of $8.0M in Feb 2015.

What was ACT Genomics's biggest round?

Its most recent round, $8.0M in Feb 2015, is also its largest on record.

What stage is ACT Genomics at?

ACT Genomics's latest named round is a Series A, in Feb 2015.

Where is ACT Genomics based?

ACT Genomics is based in Taiwan.

Companies like ACT Genomics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.